Wall Street Sees a 41% Upside to Select Medical Holdings (SEM)

Select Medical Holdings Corporation (NYSE:SEM) is one of the best dividend stocks to buy. As of December 5, the average price target for SEM suggests an upside of 34%, however, the Street high indicates an upside of 41%.

Previously, on November 5, analyst Ben Hendrix from RBC Capital kept a Buy call on Select Medical Holdings, along with a $20 price target.

In another business update, dated October 30, the company reported its Q3 2025 results. Select Medical’s revenue rose to $1,363.4 million, up 7.2% on a year-over-year basis. The company’s revenue increased in its critical illness recovery hospital, the rehabilitation hospital, and the outpatient rehabilitation segments by 4.6%, 16.2%, and 4.3% during the September quarter, respectively. The company also paid a cash dividend of $0.0625 per share on November 25.

The company’s board also announced a common share repurchase initiative with a capacity of up to $1 billion. The share repurchase program was extended from December 31, 2025, to December 31, 2027.

For FY2025, Select Medical estimates total revenue generation of $5.3-$5.5 billion, with Adjusted EBITDA ranging between $510 million and $530 million, and diluted EPS falling between $1.14 and $1.24.

Select Medical Holdings Corporation (NYSE:SEM) is an operator of hospitals and outpatient clinics across the United States, and its specializations include heart and lung conditions, neurological and orthopedic issues, cancer, work-related injuries, pediatric care, and sports rehab.

While we acknowledge the potential of SEM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Dow 20 Stocks List: Ranked By Hedge Fund Bullishness Index and 10 Unstoppable Dividend Stocks to Buy Now.

Disclosure. None.